Company intelligence / Profile preview

Cyclopharma

Saint-Beauzire, Auvergne-Rhône-Alpes, France

Ownership: Private
Development stage: Other

Overview

Cyclopharma was a French company specializing in the development and commercialization of innovative molecular imaging solutions for nuclear medicine. The company developed radiotracers used in PET and SPECT scans to support diagnosis across multiple therapeutic areas. It was acquired by Curium, a global leader in nuclear medicine.

Modalities: RadiopharmaceuticalMolecular imaging agent
Industry: Medical Imaging

Beyond the preview

Go deeper on Cyclopharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclopharma.